CardiAI has created a point-of-care device that allows patients to test themselves for Covid-19 and other chronic diseases, sending the results to their physician for personalized care. The device is part of a technology platform that uses data and analytics to enhance patient care, with advanced machine learning and data processing enabling fast and efficient prediction models. CardiAI's platform also provides appointment booking for Covid-19 diagnostics and clinical tests, as well as diagnostics solutions for corporate organizations. Founded in 2017 and based in Calgary, Canada, CardiAI is focused on improving medical diagnostics through innovative devices and software.